Picture of Quest PharmaTech logo

QPT Quest PharmaTech Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Quest PharmaTech, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.

2021
January 31st
2022
January 31st
2023
January 31st
2024
January 31st
2025
January 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line190-85-7.33-3.02-1.8
Depreciation
Non-Cash Items-18684.76.992.421.45
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-6.610.082-0.2250.249-0.156
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-2.52-0.171-0.555-0.342-0.512
Other Investing Cash Flow Items0.262-0.014-0.01400
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities0.262-0.014-0.01400
Financing Cash Flow Items0.6850
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.2990.250.6790.6850
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.950.0650.110.342-0.512